Differences in survival outcome for patients with ovarian cancer in Scotland led to an investigation of whether these differences were due to variation in presenting prognostic features or Survival for patients with ovarian cancer is improving (Balvert-Locht et al., 1991; Ries et al., 1991; Black et al., 1993 Cox's proportional hazards model was used to quantify the effect of clinical management on survival, taking account of prognostic factors (Cox, 1972) .
Differences in survival outcome for patients with ovarian cancer in Scotland led to an investigation of whether these differences were due to variation in presenting prognostic features or to the organisation and delivery of cancer services. A retrospective study of all 533 cases of ovarian cancer registered in Scotland in 1987 was carried out. After adjustment for age, stage, pathology, degree of differentiation and presence of ascites, survival improved when patients (1) were first seen by a gynaecologist (P<0.05); (2) were operated on by a gynaecologist (P<0.05); (3) had residual disease of less than 2 cm post-operatively (P<0.001); (4) were prescribed platinum chemotherapy (P<0.05); and (5) Survival for patients with ovarian cancer is improving (Balvert-Locht et al., 1991; Ries et al., 1991; Black et al., 1993) . In the west of Scotland, 3 year survival for patients under 55 years of age diagnosed between 1975 and 1988 improved from 36% to 50%. Patients aged 55-64 years showed a survival improvement from 23% to 29% over the same time period (Gillis et al., 1991) . Patients treated in teaching hospitals appeared to survive longer than those treated elsewhere. These differences were increasing with time (Gillis et al., 1991) . However, not all teaching hospitals offered a better outcome nor were all non-teaching hospitals associated with a poorer outcome (Hole & Gillis, 1993) .
This analysis (Gillis et al., 1991) was based on cancer registration data, which included age and pathology but no other major prognostic factors. This raised the question of the extent to which other prognostic factors (e.g. stage (WHO, 1976 (Cox, 1972) .
The effects of different referral routes were estimated separately from the outcomes of treatment in the following manner. Firstly, a model using only those prognostic variables found to be significant (age, stage, degree of differentiation, histological type and presence of ascites) was fitted (Table II) . Secondly, variables relating to patients' referral routes (who first saw them, who operated and attendance at a combined clinic) were added (Table III) . Thirdly, treatment variables (amount of residual disease after operation and use of chemotherapy) were considered in addition to those factors included in the first model (Table IV) (Cox, 1970 Improved survival was associated with three variables relating to referral (Table III) . These were: when the patient was initially seen by a gynaecologist (P<0.05), when a gunaecologist performed the operation (P <0.05) and attendance at a joint clinic (P<0.001). Other factors which were examined and were not related to survival were type and duration of symptoms, time from presentation to hospital referral and time from presentation to laparotomy.
Improved survival was associated with two variables relating to treatment (Table IV) . These were residual disease less than 2 cm (P<0.001) and receiving platinum chemotherapy (P <0.05). All Evidence has existed for some time that participation in clinical trials (Lennox et al., 1975; Davis et al., 1985; Karjalainen & Palva, 1989; Stiller & Draper, 1989 ) and referral to specialist centres (Stiller, 1988; Karjaainen, 1990 , Harding et al., 1993 confer survival advantage on patients with certain types of cancer. These benefits have been seen in the treatment of childhood cancers (Lennox et al., 1975; Stiller, 1988; Stiller & Draper, 1989) , teratoma (Harding et al., 1993) , multiple myeloma (Karjalainen & Palva, 1989) , nonsmall-cell lung cancer (Davis et al., 1985) and breast cancer (Karjalaien, 1990) . Our study has identified specific aspects of the clinical management of ovarian cancer which are associated with improved survival. The advantage of debulking surgery has been known for some time (Griffiths, 1975 (Tables mI and IV) . This minimise any confounding effect due to selection.
One prognostic factor we were unable to record in this study because of insufficient information was performance status (Voest et al., 1989) . In order to make some ass t of this effect, the data have been reanalysed omitting patients The age distribution of patients in this cohort was similar to other population-based studies (Ries et al., 1991; Hogberg et al., 1993) , as was stage and degree of histological differentiation (Hogberg et al., 1993) . Histological type distribution is not dissimilar to reports in the literature (Malkasian et al., 1975) . One other large series of 726 cases (Omura et al., 1991) reports the piese of ascites to be a significantly detrimental prognostic indicator. In our study, the presence of ascites was a strong and idependent prognostic factor (P<0.001) and should be considered in future studies.
The report on accptable practie in ovarian cancer management crculated to gynaecologists and surgeons in Scotland in 1992 (Management of Ovarian Cancer, 1991) could not have affected our resuls as this study refers to patients treated 4 years prior to its publication in 1991.
The effect of treatment in teaching hospitals is not statisticlly signnt in this study. The relative hazard ratio (RHR) for non-teaching compared with teaching hospitals is 1.19 using Cox's proportional hazards model and adjusting for the prognostic factors age, stage, degree of differentiation, pathological type and presnce of ascites. However, this hazard ratio is similar in size to that found in a larger study of 3,000 cases diagnosed between 1975 and 1987 (Hole & Gillis, 1993 , which produced a RHR of 1.13 and was statistically sigificant. We believe that the non-significnt finding in this study is due to insufficient numbers of patients to detect such a difference rather than being evidence of there not being an effect.
-The effect of being operated on by a specialist gynaecologist also shows the possibility of benefit (RHR = 0.86), though this is not statistically significant. We believe it will need a larger number of cases than the 76 patients who were operated on by specialist gynaecologists in this study to determine whether this effect is real.
Tlhe first four clinical management factors found to affect survival agree with those published in the Department of Health report on ovarian cancer (Management of Ovarian Cancer, 1991 
